glp-1 news oct 9 2025 Ozempic and other drugs were initially understood as a metabolism breakthrough: medicines that act like hormones to control hunger, blood sugar and weight. But as researchers probe deeper into how the GLP-1 Trends: Access & Shortages,

10.1146/annurev-physiol-021115-105347 [DOI] [PMC free article] [PubMed] [Google Scholar] Sutton, A

56 Small molecule targeted therapy (BRAF and MEK inhibitors) and immune checkpoint inhibitors (CTLA4 and PD1) have shown promising clinical outcomes

Patients carrying certain genetic markers may experience different rates of potassium retention or kidney stress when combining medications

Exercise, protein intake, sleep quality, and stress management all become critical factors in continued progress

But younger women, ages 30 to 49, are twice as likely than men to have used them

Some people also use L-carnitine for conditions of the heart and blood vessels, serious kidney disease, and many other conditions, but there is no good scientific evidence to support these uses